Jeffrey Stambough
Concepts (249)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthroplasty, Replacement, Hip | 51 | 2024 | 263 | 15.320 |
Why?
| Arthroplasty, Replacement, Knee | 43 | 2025 | 286 | 13.630 |
Why?
| Prosthesis-Related Infections | 11 | 2024 | 112 | 5.880 |
Why?
| Knee Prosthesis | 9 | 2025 | 55 | 3.520 |
Why?
| Hip Prosthesis | 9 | 2022 | 73 | 2.750 |
Why?
| Reoperation | 18 | 2024 | 461 | 2.550 |
Why?
| Osteoarthritis, Knee | 8 | 2025 | 98 | 2.510 |
Why?
| Patient Readmission | 11 | 2024 | 229 | 2.450 |
Why?
| Anesthesia, General | 4 | 2024 | 99 | 2.230 |
Why?
| Retrospective Studies | 43 | 2025 | 6274 | 2.090 |
Why?
| Knee Joint | 17 | 2025 | 165 | 1.950 |
Why?
| Postoperative Complications | 11 | 2024 | 1030 | 1.910 |
Why?
| Arthritis, Infectious | 4 | 2023 | 44 | 1.810 |
Why?
| Orthopedics | 5 | 2022 | 52 | 1.750 |
Why?
| Arthroplasty | 5 | 2023 | 28 | 1.700 |
Why?
| Humans | 92 | 2025 | 50419 | 1.590 |
Why?
| Length of Stay | 10 | 2024 | 631 | 1.480 |
Why?
| Anti-Bacterial Agents | 5 | 2024 | 751 | 1.370 |
Why?
| Pneumonia, Viral | 4 | 2020 | 169 | 1.350 |
Why?
| Coronavirus Infections | 4 | 2020 | 176 | 1.330 |
Why?
| Hospitals | 6 | 2024 | 170 | 1.250 |
Why?
| Femoral Fractures | 3 | 2023 | 41 | 1.200 |
Why?
| Opioid-Related Disorders | 5 | 2024 | 392 | 1.130 |
Why?
| Aged | 30 | 2025 | 9738 | 1.130 |
Why?
| Osteoarthritis, Hip | 3 | 2016 | 26 | 1.100 |
Why?
| Treatment Outcome | 19 | 2025 | 5265 | 1.060 |
Why?
| Patient Discharge | 6 | 2022 | 318 | 1.060 |
Why?
| Polyethylene | 5 | 2020 | 18 | 1.040 |
Why?
| Joint Instability | 4 | 2022 | 42 | 1.040 |
Why?
| Hip Fractures | 2 | 2023 | 46 | 1.010 |
Why?
| Obesity, Morbid | 2 | 2024 | 78 | 0.990 |
Why?
| Medicare | 10 | 2024 | 247 | 0.970 |
Why?
| Registries | 5 | 2024 | 565 | 0.960 |
Why?
| Debridement | 2 | 2024 | 44 | 0.960 |
Why?
| Anesthesia, Spinal | 2 | 2022 | 16 | 0.960 |
Why?
| Perioperative Care | 2 | 2016 | 42 | 0.950 |
Why?
| United States | 21 | 2024 | 5005 | 0.920 |
Why?
| Pandemics | 6 | 2022 | 553 | 0.920 |
Why?
| Femur | 5 | 2023 | 130 | 0.890 |
Why?
| Femur Head | 4 | 2019 | 25 | 0.890 |
Why?
| Aged, 80 and over | 13 | 2025 | 3233 | 0.880 |
Why?
| Prosthesis Failure | 6 | 2024 | 110 | 0.860 |
Why?
| Osteotomy | 3 | 2018 | 31 | 0.850 |
Why?
| Male | 32 | 2025 | 25866 | 0.840 |
Why?
| Femoral Neck Fractures | 2 | 2022 | 7 | 0.840 |
Why?
| Pain, Postoperative | 8 | 2024 | 163 | 0.840 |
Why?
| Middle Aged | 25 | 2025 | 12579 | 0.840 |
Why?
| Body Mass Index | 2 | 2024 | 674 | 0.830 |
Why?
| Knee Injuries | 1 | 2023 | 29 | 0.820 |
Why?
| Anemia | 1 | 2023 | 67 | 0.820 |
Why?
| Female | 33 | 2025 | 27053 | 0.800 |
Why?
| Osteoarthritis | 1 | 2023 | 59 | 0.790 |
Why?
| Bariatric Surgery | 1 | 2023 | 42 | 0.790 |
Why?
| Analgesics, Opioid | 8 | 2024 | 577 | 0.790 |
Why?
| Prosthesis Design | 10 | 2024 | 245 | 0.730 |
Why?
| Anti-Infective Agents, Local | 1 | 2021 | 27 | 0.700 |
Why?
| Acetabulum | 4 | 2020 | 38 | 0.670 |
Why?
| Narcotics | 1 | 2020 | 113 | 0.660 |
Why?
| Diabetes Mellitus | 1 | 2023 | 281 | 0.660 |
Why?
| Patient Satisfaction | 2 | 2022 | 276 | 0.650 |
Why?
| Medicaid | 2 | 2019 | 258 | 0.650 |
Why?
| Skilled Nursing Facilities | 2 | 2022 | 9 | 0.650 |
Why?
| Arthralgia | 2 | 2022 | 45 | 0.650 |
Why?
| Range of Motion, Articular | 6 | 2023 | 108 | 0.630 |
Why?
| Obesity | 2 | 2024 | 1123 | 0.630 |
Why?
| Blood Sedimentation | 1 | 2019 | 15 | 0.630 |
Why?
| Societies, Medical | 2 | 2023 | 189 | 0.630 |
Why?
| Risk Factors | 10 | 2024 | 3712 | 0.620 |
Why?
| Bone Anteversion | 1 | 2018 | 2 | 0.620 |
Why?
| Bone Nails | 1 | 2018 | 11 | 0.610 |
Why?
| Time-to-Treatment | 1 | 2019 | 73 | 0.580 |
Why?
| C-Reactive Protein | 1 | 2019 | 145 | 0.580 |
Why?
| Mupirocin | 1 | 2016 | 4 | 0.530 |
Why?
| Chlorhexidine | 1 | 2016 | 11 | 0.530 |
Why?
| Quadriceps Muscle | 3 | 2022 | 46 | 0.510 |
Why?
| Hip Joint | 2 | 2015 | 58 | 0.510 |
Why?
| Practice Guidelines as Topic | 1 | 2019 | 473 | 0.500 |
Why?
| Adult | 17 | 2024 | 13561 | 0.500 |
Why?
| Spinal Stenosis | 2 | 2010 | 13 | 0.500 |
Why?
| Surgical Wound Infection | 1 | 2016 | 115 | 0.490 |
Why?
| Pelvic Bones | 1 | 2015 | 12 | 0.480 |
Why?
| Prospective Studies | 6 | 2021 | 2378 | 0.470 |
Why?
| Time Factors | 7 | 2024 | 2933 | 0.460 |
Why?
| Clinical Protocols | 1 | 2015 | 111 | 0.450 |
Why?
| Patient Care Team | 1 | 2016 | 258 | 0.440 |
Why?
| Bone Transplantation | 2 | 2013 | 43 | 0.430 |
Why?
| Curettage | 1 | 2013 | 12 | 0.420 |
Why?
| Humerus | 1 | 2013 | 18 | 0.420 |
Why?
| Capillaries | 1 | 2013 | 50 | 0.410 |
Why?
| Decompression, Surgical | 1 | 2013 | 48 | 0.410 |
Why?
| Tibia | 3 | 2023 | 119 | 0.410 |
Why?
| Periprosthetic Fractures | 2 | 2023 | 11 | 0.400 |
Why?
| Osteocytes | 2 | 2024 | 225 | 0.360 |
Why?
| Lumbar Vertebrae | 2 | 2022 | 102 | 0.350 |
Why?
| Quality Indicators, Health Care | 2 | 2024 | 87 | 0.350 |
Why?
| Pain | 6 | 2024 | 386 | 0.350 |
Why?
| Intervertebral Disc Degeneration | 1 | 2010 | 4 | 0.340 |
Why?
| Radiography | 3 | 2019 | 482 | 0.330 |
Why?
| Muscle Strength | 2 | 2022 | 127 | 0.330 |
Why?
| Bone Morphogenetic Proteins | 1 | 2010 | 56 | 0.320 |
Why?
| Follow-Up Studies | 5 | 2019 | 2231 | 0.320 |
Why?
| Transforming Growth Factor beta | 1 | 2010 | 134 | 0.310 |
Why?
| Pain Measurement | 3 | 2024 | 271 | 0.310 |
Why?
| Spinal Fusion | 1 | 2010 | 69 | 0.310 |
Why?
| Recombinant Proteins | 1 | 2010 | 477 | 0.300 |
Why?
| Incidence | 2 | 2024 | 1027 | 0.290 |
Why?
| Adolescent | 6 | 2019 | 6453 | 0.280 |
Why?
| Osteolysis | 2 | 2018 | 74 | 0.260 |
Why?
| Tertiary Care Centers | 2 | 2023 | 78 | 0.250 |
Why?
| Referral and Consultation | 2 | 2020 | 287 | 0.250 |
Why?
| Young Adult | 5 | 2019 | 4075 | 0.230 |
Why?
| Single-Cell Analysis | 1 | 2024 | 63 | 0.220 |
Why?
| Prospective Payment System | 1 | 2024 | 5 | 0.220 |
Why?
| Leg Injuries | 1 | 2024 | 12 | 0.220 |
Why?
| Tibial Fractures | 1 | 2024 | 31 | 0.220 |
Why?
| Endrin | 1 | 2023 | 3 | 0.220 |
Why?
| Nerve Block | 1 | 2024 | 42 | 0.220 |
Why?
| Aftercare | 2 | 2022 | 72 | 0.210 |
Why?
| Polyethylenes | 1 | 2023 | 13 | 0.210 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2023 | 53 | 0.210 |
Why?
| International Classification of Diseases | 1 | 2023 | 64 | 0.210 |
Why?
| Recurrence | 1 | 2024 | 657 | 0.200 |
Why?
| Transplantation, Homologous | 1 | 2023 | 146 | 0.200 |
Why?
| Mechanotransduction, Cellular | 1 | 2023 | 39 | 0.200 |
Why?
| Bone Neoplasms | 1 | 2024 | 178 | 0.200 |
Why?
| Crowdsourcing | 1 | 2022 | 8 | 0.200 |
Why?
| Bone Diseases, Metabolic | 1 | 2023 | 74 | 0.200 |
Why?
| Lordosis | 1 | 2022 | 4 | 0.200 |
Why?
| Osteonecrosis | 1 | 2022 | 34 | 0.200 |
Why?
| Kyphosis | 1 | 2022 | 15 | 0.190 |
Why?
| Quality of Life | 3 | 2022 | 850 | 0.190 |
Why?
| Disability Evaluation | 2 | 2019 | 92 | 0.190 |
Why?
| Cost of Illness | 1 | 2022 | 115 | 0.190 |
Why?
| Metal-on-Metal Joint Prostheses | 1 | 2021 | 5 | 0.180 |
Why?
| Leg | 1 | 2022 | 123 | 0.180 |
Why?
| Hospitalization | 2 | 2023 | 677 | 0.180 |
Why?
| Anemia, Sickle Cell | 1 | 2022 | 95 | 0.180 |
Why?
| alpha-Defensins | 1 | 2021 | 3 | 0.180 |
Why?
| Bone Resorption | 1 | 2023 | 301 | 0.180 |
Why?
| Therapeutic Irrigation | 1 | 2021 | 29 | 0.180 |
Why?
| Weight Loss | 1 | 2023 | 245 | 0.180 |
Why?
| Cohort Studies | 3 | 2022 | 1451 | 0.180 |
Why?
| North America | 1 | 2020 | 65 | 0.170 |
Why?
| Polyradiculopathy | 1 | 2000 | 4 | 0.170 |
Why?
| Chromium | 2 | 2021 | 4 | 0.170 |
Why?
| Salvage Therapy | 1 | 2021 | 137 | 0.170 |
Why?
| Cobalt | 2 | 2021 | 16 | 0.170 |
Why?
| Workload | 1 | 2020 | 45 | 0.170 |
Why?
| Anesthesia, Epidural | 1 | 2000 | 25 | 0.170 |
Why?
| Comorbidity | 2 | 2018 | 621 | 0.160 |
Why?
| Health Planning Guidelines | 1 | 2019 | 15 | 0.160 |
Why?
| Hemiarthroplasty | 1 | 2019 | 6 | 0.160 |
Why?
| Leadership | 1 | 2020 | 100 | 0.160 |
Why?
| New York City | 1 | 2019 | 25 | 0.160 |
Why?
| Social Media | 1 | 2021 | 99 | 0.160 |
Why?
| Insurance, Health, Reimbursement | 1 | 2019 | 24 | 0.160 |
Why?
| North Carolina | 1 | 2019 | 57 | 0.160 |
Why?
| Physical Examination | 1 | 2019 | 94 | 0.150 |
Why?
| Sepsis | 1 | 2021 | 225 | 0.150 |
Why?
| Rotation | 1 | 2018 | 43 | 0.150 |
Why?
| Electronic Health Records | 1 | 2021 | 222 | 0.150 |
Why?
| Health Resources | 1 | 2019 | 74 | 0.150 |
Why?
| Ambulatory Surgical Procedures | 1 | 2019 | 54 | 0.150 |
Why?
| Rural Population | 1 | 2023 | 556 | 0.150 |
Why?
| Insurance Claim Review | 1 | 2018 | 34 | 0.150 |
Why?
| Recovery of Function | 2 | 2016 | 191 | 0.150 |
Why?
| Insurance, Health | 1 | 2019 | 130 | 0.140 |
Why?
| Joint Diseases | 1 | 2018 | 41 | 0.140 |
Why?
| Imaging, Three-Dimensional | 2 | 2016 | 151 | 0.140 |
Why?
| Administration, Intranasal | 1 | 2016 | 30 | 0.130 |
Why?
| Missouri | 1 | 2016 | 63 | 0.130 |
Why?
| Osteoclasts | 3 | 2024 | 427 | 0.130 |
Why?
| Child | 3 | 2019 | 6931 | 0.130 |
Why?
| Predictive Value of Tests | 1 | 2019 | 924 | 0.130 |
Why?
| Hospital Costs | 1 | 2016 | 71 | 0.130 |
Why?
| Ceramics | 1 | 2015 | 6 | 0.130 |
Why?
| Computer-Aided Design | 1 | 2016 | 22 | 0.130 |
Why?
| Eligibility Determination | 1 | 2016 | 18 | 0.120 |
Why?
| Viscosupplementation | 1 | 2015 | 1 | 0.120 |
Why?
| Hip Dislocation | 1 | 2015 | 17 | 0.120 |
Why?
| Breast Neoplasms | 1 | 2024 | 1198 | 0.120 |
Why?
| Lower Extremity | 3 | 2024 | 92 | 0.120 |
Why?
| Cost-Benefit Analysis | 1 | 2016 | 263 | 0.120 |
Why?
| Weight-Bearing | 1 | 2015 | 46 | 0.120 |
Why?
| Cartilage, Articular | 1 | 2015 | 47 | 0.120 |
Why?
| Biocompatible Materials | 1 | 2015 | 66 | 0.120 |
Why?
| Treatment Failure | 1 | 2014 | 120 | 0.110 |
Why?
| Patient Selection | 1 | 2016 | 257 | 0.110 |
Why?
| Patient Safety | 1 | 2015 | 102 | 0.110 |
Why?
| Quality Improvement | 1 | 2016 | 215 | 0.110 |
Why?
| Staphylococcal Infections | 1 | 2016 | 267 | 0.110 |
Why?
| Calcium Sulfate | 1 | 2013 | 7 | 0.110 |
Why?
| Motor Activity | 1 | 2014 | 224 | 0.110 |
Why?
| Sex Factors | 1 | 2015 | 718 | 0.100 |
Why?
| Arkansas | 1 | 2019 | 1974 | 0.100 |
Why?
| Staphylococcus aureus | 1 | 2016 | 321 | 0.100 |
Why?
| Magnetic Resonance Imaging | 2 | 2016 | 1546 | 0.090 |
Why?
| Age Factors | 1 | 2014 | 1118 | 0.090 |
Why?
| Outpatients | 2 | 2022 | 121 | 0.080 |
Why?
| Bone Morphogenetic Protein 2 | 1 | 2010 | 45 | 0.080 |
Why?
| Postoperative Period | 2 | 2023 | 171 | 0.080 |
Why?
| Mice | 3 | 2024 | 5659 | 0.080 |
Why?
| Bone Cements | 2 | 2022 | 30 | 0.080 |
Why?
| Inpatients | 2 | 2022 | 194 | 0.080 |
Why?
| Severity of Illness Index | 1 | 2010 | 976 | 0.070 |
Why?
| Prevalence | 2 | 2022 | 967 | 0.060 |
Why?
| Animals | 3 | 2024 | 13063 | 0.060 |
Why?
| Spinal Cord Compression | 1 | 2004 | 10 | 0.060 |
Why?
| Child, Preschool | 1 | 2013 | 3953 | 0.060 |
Why?
| Spinal Neoplasms | 1 | 2004 | 29 | 0.060 |
Why?
| Osteoprotegerin | 1 | 2023 | 52 | 0.050 |
Why?
| Hemangioma | 1 | 2004 | 83 | 0.050 |
Why?
| Knee | 1 | 2023 | 21 | 0.050 |
Why?
| Acute Disease | 2 | 2004 | 374 | 0.050 |
Why?
| Tumor Microenvironment | 1 | 2024 | 221 | 0.050 |
Why?
| Fracture Fixation, Internal | 1 | 2023 | 39 | 0.050 |
Why?
| Pain Management | 1 | 2024 | 180 | 0.050 |
Why?
| Ion Channels | 1 | 2023 | 74 | 0.050 |
Why?
| Transcriptome | 1 | 2024 | 314 | 0.050 |
Why?
| Pelvis | 1 | 2022 | 66 | 0.050 |
Why?
| Femur Neck | 1 | 2021 | 6 | 0.050 |
Why?
| Synovial Fluid | 1 | 2021 | 18 | 0.050 |
Why?
| Maryland | 1 | 2020 | 32 | 0.040 |
Why?
| New York | 1 | 2020 | 47 | 0.040 |
Why?
| Kentucky | 1 | 2020 | 47 | 0.040 |
Why?
| Florida | 1 | 2020 | 58 | 0.040 |
Why?
| Socioeconomic Factors | 1 | 2023 | 591 | 0.040 |
Why?
| Cell Line, Tumor | 1 | 2024 | 1393 | 0.040 |
Why?
| Dissociative Disorders | 1 | 2020 | 6 | 0.040 |
Why?
| Postural Balance | 1 | 2021 | 57 | 0.040 |
Why?
| Research Design | 1 | 2022 | 348 | 0.040 |
Why?
| Cross-Over Studies | 1 | 2021 | 230 | 0.040 |
Why?
| Gait | 1 | 2021 | 89 | 0.040 |
Why?
| Osteoblasts | 1 | 2023 | 463 | 0.040 |
Why?
| Gene Expression Profiling | 1 | 2024 | 1020 | 0.040 |
Why?
| Bone and Bones | 1 | 2023 | 481 | 0.040 |
Why?
| Chromium Alloys | 1 | 2019 | 6 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2021 | 855 | 0.040 |
Why?
| Mortality | 1 | 2019 | 96 | 0.040 |
Why?
| Reproducibility of Results | 1 | 2022 | 1181 | 0.040 |
Why?
| Morbidity | 1 | 2019 | 130 | 0.040 |
Why?
| Muscle, Skeletal | 1 | 2022 | 786 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2019 | 732 | 0.030 |
Why?
| Awards and Prizes | 1 | 2016 | 18 | 0.030 |
Why?
| Ankle Joint | 1 | 2015 | 22 | 0.030 |
Why?
| Chi-Square Distribution | 1 | 2016 | 275 | 0.030 |
Why?
| Databases, Factual | 1 | 2016 | 676 | 0.030 |
Why?
| Tomography, X-Ray Computed | 1 | 2016 | 1163 | 0.020 |
Why?
| Thoracic Vertebrae | 1 | 2004 | 36 | 0.010 |
Why?
|
|
Stambough's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|